Acquistion of Assets and more.
The question how DECN would/could finance the acquisition of assets, will certainly soon be disclosed. But the wording “assets” in their NT10K filing from last week is clear: The Registrant’s subsidiary Pharma Tech Solutions, Inc. is completing an acquisition of certain healthcare assets from a
privately owned concern and this event also includes changes of registration with federal regulatory bodies as well as primary private registrars.
This event transaction closing is expected to be completed by April 14, 2014. In short, this is not about an acquisition of a company, it is about an acquisition of Assets and under assets a lot could be understood and I could even speculate here about what the Assets could be and if my nose is right, it could be a surprise. But, very soon, we will know for sure,without entering speculation.
Based on the past, DECN avoided debt-financing which from a balance-sheet point of view has been smart. If then so, I guess, DECN will do equity financing as most of the companies are doing when they make an acquisition and if the acquisition adds value to the company in the future, then the dilution should be well balanced I would guess. What I do not understand the recent hoopla about the issuance of preferred – or common shares to get financed. Well at the end it is the same: With common shares it is the 1 to 1 factor and with preferred shares one has to calculate the factor based on the given ratio and maybe of interest as well , if those shares would have certain rights, like voting rights or whatever, but the end result is clear from the start when it comes to calculate the dilution by simply multiplying the given factor from PFD to Common.
THIS PART I READ ON ANOTHER BOARD AND I LOVE IT.
There are now 3 lawyers assigned to counter the J&J appeal by the Federal government. Two top lawyers from the USPTO have been assigned to assist the topest lawyer of all from the Solicitor General's office who will sign the government's briefs and make the arguments in open court. All three lawyers assigned have clerked for judges in the Circuit (patent) court, and cut their teeth writing the opinions made by the Circuit Court. This is a veritable high level legal Who's Who aligned against J&J.
The conclusion from this message would then be: The government has even more resources than J&J and it would be advisable to take notice, that this time the government is on the side of DECN. Seems DECN has done something right or better said, the Management of DECN handles this case in the most professional way.
